V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019708 | 220008628 | 1.73 | 80.6 | Adjuvant (A) | 2015-03-29 | 2015-03-29 | Cytarabine intrathecal | N | N | 220032565 | CYTARABINE INTRATHECAL |
| 220019709 | 220008629 | null | 61 | Curative (C) | 2017-06-13 | 2017-06-14 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032572 | OXALIPLATIN + MDG |
| 220019710 | 220008634 | 1.83 | null | Curative (C) | 2014-10-13 | 2014-10-14 | Cytarabine intrathecal | 02 | N | 220032602 | CYTARABINE INTRATHECAL |
| 220019711 | 220014659 | 1.73 | 77.6 | Curative (C) | 2016-03-07 | 2016-03-15 | Alemtuzumab | 1 | N | 220032603 | ALEMTUZUMAB |
| 220019712 | 220008641 | 1.78 | 66.8 | Curative (C) | 2016-03-11 | 2016-03-11 | PONATINIB | Y | N | 220032610 | IRINOTECAN + MDG |
| 220019713 | 220018014 | 1.85 | 87.7 | Adjuvant (A) | 2014-11-04 | 2014-11-11 | Irinotecan + Modified De Gramont | 02 | N | 220032635 | CISPLATIN + GEMCITABINE |
| 220019714 | 220008654 | 1.55 | 66.2 | Curative (C) | null | 2016-10-15 | Fludarabine + Melphalan RIC Allo | null | N | 220032654 | GEMTUZUMAB OZOGAMICIN |
| 220019715 | 220008655 | null | 86.2 | Curative (C) | 2016-02-09 | 2016-02-09 | CARBOPLATIN + PACLITAXEL | N | Y | 220032655 | CARBOPLATIN + PACLITAXEL |
| 220019716 | 220014668 | 1.69 | 80.1 | Curative (C) | 2014-08-28 | 2015-01-15 | Paclitaxel (2 or 3 weekly) | Y | N | 220032656 | PACLITAXEL |
| 220019717 | 220008660 | 1.54 | 76.5 | null | 2018-09-30 | 2018-09-30 | Arsenic trioxide + Tretinoin | N | N | 220032658 | ARSENIC TRIOXIDE + TRETINOIN |
| 220019718 | 220008667 | null | 0 | Curative (C) | 2013-01-13 | 2014-06-09 | FLUOROURACIL + OXALIPLATIN | null | null | 220032681 | FLUDARABINE + MELPHALAN |
| 220019719 | 220008677 | null | 85.2 | Palliative (P) | 2014-02-26 | 2014-02-27 | Irinotecan + Modified De Gramont | 2 | N | 220032695 | METHOTREXATE |
| 220019721 | 220008684 | 1.9 | 77.8 | Curative (C) | 2015-10-08 | 2015-10-08 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220032713 | ALEMTUZUMAB |
| 220019722 | 220008686 | 1.67 | 81.4 | Disease modification (D) | 2014-07-08 | 2014-10-01 | Fludarabine + Melphalan RIC Allo | null | null | 220032721 | ECX |
| 220019723 | 220014678 | 1.69 | 80 | Curative (C) | 2018-01-01 | 2018-02-12 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | null | N | 220032728 | CLOFARABINE + CYTARABINE |
| 220019724 | 220008697 | 1.7 | 46 | Not known (9) | 2017-04-13 | 2017-04-18 | PACLITAXEL | 99 | N | 220032730 | PACLITAXEL |
| 220019725 | 220008699 | 1.78 | 63.65 | Curative (C) | 2017-04-20 | 2017-04-20 | METHOTREXATE | N | N | 220032740 | DOCETAXEL |
| 220019726 | 220008700 | 1.75 | 88.6 | Disease modification (D) | 2017-10-10 | 2017-10-10 | ECX | 2 | N | 220032742 | METHOTREXATE |
| 220019727 | 220008701 | 1.72 | 58 | Adjuvant (A) | 2014-04-29 | 2014-04-29 | PONATINIB | N | N | 220032750 | OXALIPLATIN + MDG |
| 220019728 | 220008704 | 1.63 | 86.3 | Curative (C) | 2015-05-18 | 2015-05-18 | Docetaxel 75mg/m2 (21 day) | N | N | 220032770 | IRINOTECAN + MDG |
| 220019729 | 220008707 | null | 70 | Curative (C) | 2014-01-05 | 2014-11-28 | Arsenic trioxide + Tretinoin | 02 | N | 220032778 | ARSENIC TRIOXIDE + TRETINOIN |
| 220019730 | 220008712 | 1.69 | 65.1 | Curative (C) | 2016-04-29 | 2016-08-11 | Clofarabine + Cytarabine | N | N | 220032784 | CISPLATIN + GEMCITABINE |
| 220019731 | 220008716 | null | 8.9 | Curative (C) | 2013-07-22 | 2013-08-06 | Mitox + Tretinoin Spanish Course 3 | N | null | 220032789 | MITOXANTRONE |
| 220019732 | 220008718 | 1.76 | 77 | Curative (C) | 2017-02-17 | 2017-03-01 | METHOTREXATE | N | null | 220032794 | CLOFARABINE + CYTARABINE |
| 220019734 | 220022106 | null | 52.6 | Palliative (P) | 2017-03-15 | 2017-03-30 | FLUOROURACIL + OXALIPLATIN | N | N | 220032803 | CISPLATIN + GEMCITABINE |
| 220019735 | 220008730 | 1.6 | 70 | Curative (C) | 2015-07-03 | 2015-12-02 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220032856 | METHOTREXATE |
| 220019736 | 220008734 | 1.68 | null | Palliative (P) | null | 2017-07-21 | UKALL14- Cons Cycle 1 | N | N | 220032862 | OXALIPLATIN + MDG |
| 220019737 | 220008735 | null | 68 | Disease modification (D) | 2016-09-15 | 2017-02-27 | FLUOROURACIL + OXALIPLATIN | N | N | 220032863 | PONATINIB |
| 220019738 | 220008738 | 1.83 | 16.9 | Disease modification (D) | 2015-11-21 | 2016-02-03 | Arsenic Triox + Tretinoin Ind W5-8 | Y | N | 220032865 | ARSENIC TRIOXIDE + TRETINOIN |
| 220019739 | 220008742 | 1.67 | 85 | Curative (C) | 2018-05-17 | 2018-05-19 | IDARUBICIN | 2 | N | 220032872 | IDARUBICIN |
| 220019740 | 220014700 | 1.75 | 80.6 | Curative (C) | null | 2015-04-03 | Docetaxel 75mg/m2 (21 day) | N | N | 220032874 | GEMCARBO |
| 220019741 | 220008746 | null | 15.8 | Palliative (P) | 2019-01-17 | 2019-01-31 | UKALL14- Ph 1 Induction | 02 | N | 220032880 | PONATINIB |
| 220019742 | 220008754 | 1.6 | 48.7 | null | 2018-07-12 | 2018-07-12 | Arsenic trioxide + Tretinoin | 02 | N | 220032908 | ARSENIC TRIOXIDE + TRETINOIN |
| 220019743 | 220008757 | 1.65 | null | Disease modification (D) | 2015-08-24 | 2015-09-21 | Clofarabine + Cytarabine | null | null | 220032911 | PONATINIB |
| 220019744 | 220008761 | 1.69 | 64 | Disease modification (D) | 2014-10-21 | 2014-11-14 | CARBOPLATIN + GEMCITABINE | 02 | N | 220032919 | GEMCARBO |
| 220019745 | 220008763 | 1.78 | 66.4 | Palliative (P) | 2015-10-29 | 2015-11-17 | UKALL14- Ph 2 Induction | 02 | null | 220032920 | CLOFARABINE + CYTARABINE |
| 220019746 | 220014707 | 1.61 | 77.8 | Disease modification (D) | null | 2018-01-31 | CARBOPLATIN + GEMCITABINE | 02 | N | 220032932 | GEMCARBO |
| 220019747 | 220008767 | 1.75 | 74 | Not known (9) | 2016-02-17 | 2016-02-23 | Oxaliplatin + Modified de Gramont | N | N | 220032937 | IRINOTECAN + MDG |
| 220019748 | 220018035 | 1.96 | null | Curative (C) | 2016-06-23 | 2016-09-27 | Carboplatin + Etoposide iv&po | N | null | 220032973 | CARBOPLATIN + ETOPOSIDE |
| 220019749 | 220008773 | 1.85 | 75.9 | Palliative (P) | 2017-05-30 | 2017-06-11 | Arsenic trioxide + Tretinoin | N | N | 220032980 | ARSENIC TRIOXIDE + TRETINOIN |
| 220019750 | 220008775 | 1.65 | 96.3 | Curative (C) | null | 2016-11-15 | IDARUBICIN | null | null | 220032988 | IDARUBICIN |
| 220019751 | 220008776 | 1.69 | 78.1 | Curative (C) | 2015-05-06 | 2015-05-06 | Arsenic Triox + Tretinoin Ind W5-8 | null | null | 220032991 | ARSENIC TRIOXIDE + TRETINOIN |
| 220019752 | 220008780 | 1.57 | 81.7 | Curative (C) | 2017-04-16 | 2017-04-17 | IDARUBICIN | N | N | 220032998 | IDARUBICIN |
| 220019753 | 220008784 | 1.72 | 80 | Adjuvant (A) | 2013-12-01 | 2014-03-15 | GemCarbo Days 1+8 | N | N | 220033010 | OXALIPLATIN + MDG |
| 220019754 | 220020973 | 1.63 | 72.4 | Disease modification (D) | 2017-12-03 | 2018-04-07 | Mitox + Tretinoin Spanish Course 3 | N | N | 220033034 | MITOXANTRONE |
| 220019755 | 220008790 | 1.48 | 58.1 | Curative (C) | 2013-07-20 | 2013-07-20 | UKALL14- Ph 2 Induction | N | null | 220033039 | METHOTREXATE |
| 220019756 | 220014721 | 1.63 | 58.4 | Curative (C) | 2015-09-05 | 2015-10-08 | CARBOPLATIN + GEMCITABINE | N | N | 220033073 | GEMCARBO |
| 220019758 | 220014726 | 1.56 | 81 | Curative (C) | null | 2017-01-22 | Arsenic trioxide + Tretinoin | Y | N | 220033114 | ARSENIC TRIOXIDE + TRETINOIN |
| 220019759 | 220008810 | 1.73 | 78.8 | Disease modification (D) | 2013-12-10 | 2013-12-10 | Mitoxantrone | N | N | 220033117 | MITOXANTRONE |
| 220019760 | 220008814 | 1.61 | 62.5 | Curative (C) | 2016-10-03 | 2016-10-03 | Paclitaxel (2 or 3 weekly) | N | N | 220033122 | PACLITAXEL |